7 Attachment G: Participant Experience Survey_Antibiotic S

The AHRQ Safety Program for Telemedicine: Improving the Diagnostic Process and Improving Antibiotic Use

Att G_Participant Experience Survey_Antibiotic Stewardship Cohort_1.26.2023

OMB: 0935-0265

Document [docx]
Download: docx | pdf

Shape1

Form Approved
OMB No. 0935-XXXX
Exp. Date XX/XX/20XX

Attachment G: Participant Experience Survey—Antibiotic Stewardship Cohort

Participant Experience Survey

Antibiotic Stewardship Cohort



Thank you for your participation in the AHRQ Safety Program for Improving Antibiotic Use in Telemedicine (“the Safety Program”). The following questions pertain to your experience implementing the AHRQ Safety Program for Telemedicine: Improving Antibiotic Use (“the Safety Program”)


  1. What is the most important change you implemented to achieve your antibiotic stewardship goals? (open-ended response)



  1. What did you or your practice measure to determine whether your antibiotic stewardship goals were met? (open-ended response)



  1. How did you or your practice ensure adequate support to implement the Safety Program? (open-ended response)



  1. How did clinicians within your practice support implementation of the Safety Program? (open-ended response)



  1. Are members of your practice aware of the Four Moments of Antibiotic Decision Making?



Yes No



  1. Have clinicians been incorporating the Four Moments of Antibiotic Decision Making into their daily clinical practice?

Yes No

6a. Why or why not? (open-ended response)



  1. How did non-clinician staff within your practice support implementation of the Safety Program? (open-ended response)


  1. In addition to the Four Moments Framework, did you implement any other processes or procedures to support your antibiotic stewardship goals? (open-ended response)


  1. What barriers did you experience while implementing the Safety Program in your practice? (Please select all that apply)

Health system-level barriers

Practice-level barriers (e.g., leadership not invested in the program)

Hesitation among colleagues

Resistance among patients

Other (please specify)



9a. For each barrier type selected, please give a specific example. (open-ended response)



10. What changes have you or your practice made to ensure proper antibiotic prescribing practices are sustained? (open-ended response)



11. Which of the following content areas included in the Safety Program were helpful to your daily practice? (Select all that apply)

Community-acquired pneumonia

Sinusitis

Acute otitis media

Influenza

Bronchitis

Respiratory tract infection

Urinary tract infections

Skin and soft tissue infections

Sexually transmitted infections

Antibiotic allergy assessment

Other (please specify)



12. Were there specific tools or resources in the Safety Program that you found particularly helpful? Please list these.(open-ended response)



13. What additional content would have been helpful to include in the Safety Program? (open-ended response)









Shape2

Public reporting burden for this collection of information is estimated to average 20 minutes per response, the estimated time required to complete the survey. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer Attention: PRA, Paperwork Reduction Project (0935-XXXX) AHRQ, 540 Gaither Road, Room # 5036, Rockville, MD 20850.


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorHeather Hussey
File Modified0000-00-00
File Created2023-07-30

© 2024 OMB.report | Privacy Policy